High-Resolution Melting Analysis Market Size (2024 - 2029)

The High-Resolution Melting Analysis Market is projected to experience growth due to its increasing application in understanding genetic disorders and infectious diseases, a trend that was notably amplified during the COVID-19 pandemic. The technique's ability to differentiate between various viral strains and its effectiveness in studying genetic variations have contributed to its expanded use. Despite the market's positive trajectory, driven by the rising demand for advanced diagnostic methods and the growing incidence of rare genetic diseases, technical limitations of HRM analysis pose challenges to its growth.

Market Size of High-Resolution Melting Analysis Industry

High-Resolution Melting Analysis Market Summary
Study Period 2021 - 2029
Market Size (2024) USD 265.59 Million
Market Size (2029) USD 327.92 Million
CAGR (2024 - 2029) 4.31 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

High-Resolution Melting Analysis Market Major Players

*Disclaimer: Major Players sorted in no particular order

High-Resolution Melting Analysis Market Analysis

The High-Resolution Melting Analysis Market size is estimated at USD 265.59 million in 2024, and is expected to reach USD 327.92 million by 2029, growing at a CAGR of 4.31% during the forecast period (2024-2029).

The High-Resolution Melting (HRM) analysis is one of the novel techniques that help researchers understand the variations in nucleic acid sequences. Therefore, this technique was widely used during the COVID-19 pandemic. The HRM analysis is used to differentiate the various types of viruses and their composition. The researchers used HRM analysis to discriminate between the SARS-CoV-2 Omicron variants BA.1 and BA.2. Similarly, mutations in the coronavirus were studied with the help of HRM analysis during the pandemic. As per the September 2022 data published by Biochemistry and Biophysics Journal, it was observed that HRM analysis played a key role while differentiating between various strains of the coronavirus. It also contributed largely to understanding the characteristics of the coronavirus and its nuclear composition. Hence, with the effectiveness of HRM analysis, it is believed that the market studied was positively affected during the pandemic. Moreover, even after the pandemic, there is a growing use of HRM analysis which may drive market growth in the post-pandemic era.

The primary factor contributing to the market's growth is the increase in genetic disorders and infectious diseases. According to the WHO 2021 data, approximately 50,000 people die daily from contagious diseases. 30 new diseases have surfaced in the last 20 years, threatening the health of hundreds of millions of people. The rising burden of infectious diseases globally contributes mainly to market growth. Furthermore, the growing usage of HRM (High-Resolution Melting) in identifying pathogens and the advantages of HRM over other genotyping techniques are boosting the market growth. However, the HRM analysis's technical limitations are the market growth's major drawback.

Furthermore, the increasing occurrence of rare genetic diseases is augmenting the demand for novel techniques, such as HRM analysis, to understand the cause of the disease and provide better treatments. The research suggests that around 70% of rare diseases have genetic causes. Data published by Research Centre for Medical Genetics in August 2021 indicates that there were more than 45,000 people across the rural areas of Europe with rare hereditary diseases. Similarly, as per the Orphanet portal of rare diseases, around 10,500 rare diseases are registered worldwide as of 2022. With an increasing rare genetic disease burden, it is expected that the use of HRM analysis will increase, which is believed to propel market growth.

However, technical limitations associated with HRM analysis are expected to hinder market growth to some extent.

High-Resolution Melting Analysis Industry Segmentation

HRM analysis is a relatively new, post-PCR analysis method used to identify variations in nucleic acid sequences. The method is based on detecting small differences in PCR melting curves. It is enabled by improved dsDNA-binding dyes used in conjunction with real-time PCR instrumentation, precise temperature ramp control, and advanced data capture capabilities. 

The High-Resolution Melting Analysis Market is Segmented by Product and Service (Reagents and Consumables, Instruments, Software, and Services), Application (SNP Genotyping, Mutation Discovery, Pathogen Identification, and Other Applications), End-user (Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Other End-users), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Product and Service
Reagents and Consumables
Instruments
Software and Services
By Application
SNP Genotyping
Mutation Discovery
Pathogen Identification
Other Applications
By End-user
Research Laboratories and Academic Institutes
Pharmaceutical and Biotechnology Companies
Other End-users
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

High-Resolution Melting Analysis Market Size Summary

The High-Resolution Melting (HRM) analysis market is poised for growth, driven by its increasing application in genetic research and infectious disease diagnostics. This innovative technique gained prominence during the COVID-19 pandemic, where it was instrumental in differentiating between various strains of the virus, such as the SARS-CoV-2 Omicron variants. The effectiveness of HRM analysis in understanding nucleic acid sequence variations has continued to bolster its adoption beyond the pandemic. The rising incidence of genetic disorders and infectious diseases globally further propels the demand for HRM analysis, as it offers advantages over traditional genotyping methods. Despite its technical limitations, the market is expected to expand, supported by the growing need for advanced diagnostic tools in the face of emerging health challenges.

North America is anticipated to lead the HRM analysis market, attributed to its robust healthcare infrastructure, high prevalence of genetic and infectious diseases, and the presence of key industry players. The region benefits from supportive government initiatives and research partnerships that enhance market growth. The United States, in particular, is a significant contributor due to its developed healthcare market and favorable policies. The increasing focus on genomics and personalized medicine, alongside advancements in SNP genotyping, is expected to drive the market further. The competitive landscape features major companies like Thermo Fisher Scientific, Bio-Rad Laboratories, and Qiagen, which are actively involved in product development and strategic partnerships to strengthen their market position.

Explore More

High-Resolution Melting Analysis Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Prevalence of Genetic Disorders and Infectious Diseases

      2. 1.2.2 Advantages of HRM over Other Genotyping Technologies

      3. 1.2.3 Use of HRM in Pathogen Identification

    3. 1.3 Market Restraints

      1. 1.3.1 Technical Limitations Associated With HRM

    4. 1.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size - Value in USD Million)

    1. 2.1 By Product and Service

      1. 2.1.1 Reagents and Consumables

      2. 2.1.2 Instruments

      3. 2.1.3 Software and Services

    2. 2.2 By Application

      1. 2.2.1 SNP Genotyping

      2. 2.2.2 Mutation Discovery

      3. 2.2.3 Pathogen Identification

      4. 2.2.4 Other Applications

    3. 2.3 By End-user

      1. 2.3.1 Research Laboratories and Academic Institutes

      2. 2.3.2 Pharmaceutical and Biotechnology Companies

      3. 2.3.3 Other End-users

    4. 2.4 By Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

High-Resolution Melting Analysis Market Size FAQs

The High-Resolution Melting Analysis Market size is expected to reach USD 265.59 million in 2024 and grow at a CAGR of 4.31% to reach USD 327.92 million by 2029.

In 2024, the High-Resolution Melting Analysis Market size is expected to reach USD 265.59 million.

High-Resolution Melting Analysis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2024 - 2029)